We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$18.2B
Cap. Flow
-$36B
Cap. Flow %
-6.94%
Top 10 Hldgs %
29.96%
Holding
15,912
New
1,749
Increased
6,361
Reduced
6,148
Closed
1,439

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.78B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$973M
3
DIS icon
Walt Disney
DIS
+$588M
4
LLY icon
Eli Lilly
LLY
+$569M
5
T icon
AT&T
T
+$529M

Sector Composition

Rank Sector Weight
1 Technology 3.4%
2 Healthcare 3.08%
3 Financials 2.41%
4 Consumer Discretionary 2.33%
5 Industrials 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLZ icon
12126
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$28M
$47.9K ﹤0.01%
+60
New +$42.3K
ARKO icon
12127
PUT
ARKO Corp
ARKO
$544M
$47.9K ﹤0.01%
8,400
+8,300
+8,300% +$60.6K
VIVS
12128
VivoSim Labs
VIVS
$1.13M
$47.8K ﹤0.01%
+3,865
New +$48.1K
CGEN icon
12129
PUT
Compugen
CGEN
$228M
$47.7K ﹤0.01%
18,500
+4,800
+35% +$11.2K
BWB icon
12130
PUT
Bridgewater Bancshares
BWB
$620M
$47.7K ﹤0.01%
4,100
-700
-15% -$8.53K
STLN
12131
Starling Oncology
STLN
$657M
$47.6K ﹤0.01%
30,146
-113,694
-79% -$216K
PLX icon
12132
Protalix BioTherapeutics
PLX
$179M
$47.6K ﹤0.01%
+37,788
New +$56.4K
JVA icon
12133
Coffee Holding Co
JVA
$20.2M
$47.6K ﹤0.01%
30,098
+5,673
+23% +$6.8K
LILA icon
12134
PUT
Liberty Latin America Class A
LILA
$1.69B
$47.4K ﹤0.01%
10,010
-588
-6% -$2.69K
PANL icon
12135
PUT
Pangaea Logistics
PANL
$487M
$47.4K ﹤0.01%
6,800
+5,000
+278% +$40.9K
HOWL icon
12136
PUT
Werewolf Therapeutics
HOWL
$19.7M
$47.3K ﹤0.01%
7,300
+7,200
+7,200% +$42K
MACK
12137
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$47.3K ﹤0.01%
3,200
-2,300
-42% -$32.3K
NHC icon
12138
CALL
National Healthcare
NHC
$3.5B
$47.3K ﹤0.01%
+500
New +$47.3K
GPMT
12139
PUT
Granite Point Mortgage Trust
GPMT
$57.4M
$47.2K ﹤0.01%
9,900
+2,300
+30% +$12K
RNST icon
12140
PUT
Renasant Corp
RNST
$3.98B
$47K ﹤0.01%
+1,500
New +$47K
MVST icon
12141
CALL
Microvast
MVST
$322M
$47K ﹤0.01%
56,100
-51,000
-48% -$45.5K
TSE
12142
PUT
DELISTED
Trinseo
TSE
$46.9K ﹤0.01%
12,400
+9,300
+300% +$49.6K
LILAK icon
12143
PUT
Liberty Latin America Class C
LILAK
$1.66B
$46.8K ﹤0.01%
7,370
+7,040
+2,133% +$43.5K
VFS icon
12144
VinFast Auto
VFS
$7.42B
$46.7K ﹤0.01%
9,399
+8,389
+831% +$47.1K
VVX icon
12145
PUT
V2X
VVX
$2.6B
$46.7K ﹤0.01%
1,000
+800
+400% +$32.7K
FCF icon
12146
First Commonwealth Financial
FCF
$2.18B
$46.5K ﹤0.01%
+3,344
New +$46.2K
PKBK icon
12147
PUT
Parke Bancorp
PKBK
$413M
$46.5K ﹤0.01%
2,700
-200
-7% -$3.52K
ACRS icon
12148
CALL
Aclaris Therapeutics
ACRS
$851M
$46.5K ﹤0.01%
37,500
+20,200
+117% +$24.1K
ASST icon
12149
Strive Inc
ASST
$1.05B
$46.5K ﹤0.01%
652
+405
+164% +$21.5K
CADE
12150
PUT
DELISTED
Cadence Bank
CADE
$46.4K ﹤0.01%
1,600
-1,100
-41% -$30.6K

Similar funds

Ken Griffin's Q1 2024 Portfolio in Review

As of Q1 2024, Ken Griffin held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ken Griffin withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in TD Synnex worth $245M.

  • Ken Griffin's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
  • Ken Griffin added most to Hess in Q1 2024, an estimated $1.28B increase.
  • Ken Griffin's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
  • Ken Griffin fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
  • Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
  • Ken Griffin opened 1,749 new positions and closed 1,439 in Q1 2024.
  • Ken Griffin's portfolio value rose 3.6% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.